November 17, 2009 08:30 ET

ONE Holdings Announces Filing for NASDAQ Listing and Name Change

ONE Also Launches New Site:

MIAMI, FL--(Marketwire - November 17, 2009) - ONE Bio Corp. (formerly ONE Holdings, Corp.) ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced it has filed an application to list its common stock on the NASDAQ Capital Market and that effective immediately it has changed its name to ONE Bio Corp. and will begin trading immediately under the new symbol ONBI.

The Company believes it currently fulfills or will shortly meet all applicable NASDAQ listing requirements. The Company's shareholders recently approved a 5 to 1 reverse stock split of the Company's common stock, which will assist ONE in meeting the minimum stock price requirement required by NASDAQ for listing. The Company's listing application is subject to review and approval by NASDAQ's Listing Qualifications Department for compliance with all NASDAQ Capital Market standards.

The Company also announced it has changed its name from ONE Holdings, Corp. to ONE Bio Corp. Simultaneously with the name change, the Company also launched its newly redesigned website. Investors may visit the Company's website at

"The proposed move to the NASDAQ Capital Market, subject to approval by NASDAQ, is an important step in establishing ONE Bio as an internationally recognized green process manufacturer. A NASDAQ listing should allow our Company to gain exposure and be recognized by a broader segment of the investment community," stated the company's CEO Marius Silvasan. "Our corporate name change reinforces our commitment to develop the ONE Bio brand as an innovative leader in bioengineering."

ONE Bio's common stock will continue to trade on the OTCBB under the new symbol, ONBI.

About ONE Bio Corp.

ONE Bio Corp. ("ONE") (OTCBB: ONBI) (, headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE's growth plan targets an aggressive acquisition driven strategy supported by strong organic growth. Through ONE, small private companies gain access to capital, experienced management and strategic insight. ONE builds strong synergies amongst all subsidiaries to enhance shareholder value. ONE is working with each subsidiary to promote organic and acquisition driven growth.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information